Uroplasty (NSDQ:UPI) notched a reimbursement win with Independence Blue Cross now covering the Urgent PC device.
Uroplasty Inc.
Uroplasty lands expanded reimbursement for overactive bladder treatment system
Listen to Uroplasty Q2 2014 earnings call
Uroplasty jumps on reimbursement win from Humana
Baxter names Young new treasurer | Personnel Moves
Uroplasty dodges 2 class action lawsuits
Uroplasty’s new CFO hails from Synovis | Personnel Moves
New Rotation Medical CEO hails from Zimmer, Covidien | Personnel Moves
Minnesota-based orthotics company Rotation Medical appointed Martha Shadan as the new president & CEO.
Uroplasty touts positive 3-year outcomes for neurostimulation in treatment of overactive bladder
Medical device company Uroplasty (NSDQ:UPI) will publish the results of a 3-year study on percutaneous tibial nerve stimulation in treatment of overactive bladder. The findings are slated to appear in the June edition of the The Journal of Urology.
Study patients received an average of 1.1 treatments per month and experienced improved outcomes, including reduced voiding frequency and acute urges to urinate, according to a press release.
Orthofix makes Buxton its permanent CFO
Medtronic closes strategic investment in LifeTech | Wall Street Beat
Medtronic (NYSE:MDT) said it’s closed a $66 million investment in Chinese medical device company LifeTech Scientific (HK:8122).